Skip to main content
. 2023 Jul 17;69(7):e20230500. doi: 10.1590/1806-9282.20230500

Table 1. Characteristics of the study population.

Group 1 (n=83) Group 2 (n=82) Group 3 (n=82) p-value
Age (years) 18.0 (16.0–27.0)A.B 22.0 (20.7–26.0) 25.0 (21.0–30.0) <0.0001
BMI (kg/m2) 32.3 (28.6–33.9) 30.8 (28.6–32.4) 30.9 (29.0–32.9) 0.05
Gestational age (weeks) 40.1 (39.0–40.5) 39.3 (38.1–40.2) 39.6 (37.7–40.7) 0.05
Birth weight (g) 3180.0 (474) 3207 (439) 3139 (543) 0.605
Apgar score at 1st minute 8 (6–8)A.B 8 (8–8) 8 (8–8) 0.0004
Apgar score at 5th minute 9 (9–9) 9 (9–9) 9 (9–9) >0.9999

Group 1: analgesia performed in patients with cervical dilatation ≤4.0 cm; Group 2: analgesia performed in patients with cervical dilatation between 5.0 and 8.0 cm; Group 3: analgesia performed in patients with cervical dilatation ≥9.0 cm. BMI: body mass index; Kruskal-Wallis median (interquartile range); ANOVA mean (standard deviation); AGroup 1 vs. Group 2; BGroup 1 vs. Group 3.